Mattingly, Gregory

The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder

Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 1,545

Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial

Janik, A., Qiu, X., Lane, R., Popova, V., Drevets, W. C., Canuso, C. M., Macaluso, M., Mattingly, G. W., Shelton, R. C., Zajecka, J. M., et al. (2025) · JAMA Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 54

The impact of cognitive challenges in major depression: the role of the primary care physician

Mattingly, G., Anderson, R. H., Mattingly, S. G., & Anderson, E. Q. (2016) · Postgraduate Medicine

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 24

Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents

Maletic, V., Mattingly, G. W., & Earnest, J. (2024) · Expert Review of Neurotherapeutics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 2